Growth Metrics

Verastem (VSTM) Operating Income (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -153.03%
Dec 31, 2025 307.95%
Sep 30, 2025 6.97%
Jun 30, 2025 0.93%
Mar 31, 2025 -39.84%
Dec 31, 2024 14.69%
Sep 30, 2024 -102.60%
Jun 30, 2024 34.86%
Mar 31, 2024 9.89%
Dec 31, 2023 -46.13%
Sep 30, 2023 -5.01%
Jun 30, 2023 -4.90%
Mar 31, 2023 -14.83%
Dec 31, 2022 4.87%
Sep 30, 2022 17.26%
Jun 30, 2022 -26.04%
Mar 31, 2022 -2.84%
Dec 31, 2021 -11.22%
Sep 30, 2021 6.89%
Jun 30, 2021 -13.01%
Mar 31, 2021 15.79%
Dec 31, 2020 -211.57%
Sep 30, 2020 170.62%
Jun 30, 2020 19.33%
Mar 31, 2020 20.82%
Dec 31, 2019 -27.54%
Sep 30, 2019 31.81%
Jun 30, 2019 -10.40%
Mar 31, 2019 -1.20%
Dec 31, 2018 -58.83%
Sep 30, 2018 -18.55%
Jun 30, 2018 12.36%
Mar 31, 2018 -15.01%
Dec 31, 2017 21.98%
Sep 30, 2017 -71.81%
Jun 30, 2017 -2.43%
Mar 31, 2017 -11.42%
Dec 31, 2016 -46.42%
Sep 30, 2016 7.46%
Jun 30, 2016 -3.26%
Mar 31, 2016 29.49%
Dec 31, 2015 23.00%
Sep 30, 2015 -0.47%
Jun 30, 2015 -1.44%
Mar 31, 2015 -8.89%
Dec 31, 2014 -4.56%
Sep 30, 2014 -2.30%
Jun 30, 2014 0.36%
Mar 31, 2014 -15.28%
Dec 31, 2013 -7.04%
Sep 30, 2013 -3.50%
Jun 30, 2013 -13.25%
Mar 31, 2013 -13.85%
Dec 31, 2012 23.53%
Sep 30, 2012 -51.25%
Jun 30, 2012 0.46%
Mar 31, 2012 -15.08%
Dec 31, 2011 -48.75%
Sep 30, 2011 -62.86%
Jun 30, 2011 -116.84%